Pfizer vaccine for children 5-11 years, Locatelli: “In Italy by Christmas”

Pfizer vaccine for children 5-11 years, Locatelli: “In Italy by Christmas”
Pfizer vaccine for children 5-11 years, Locatelli: “In Italy by Christmas”

“The Pfizer vaccine in Italy also for children aged 5 to 11 by Christmas”. Franco Locatelli, president of the Higher Health Council and coordinator of the Scientific Technical Committee (Cts), announces the imminent launch of the anti covid vaccine for the 5-11 year old age group. “Pfizer is a safe vaccine approved in the United States by the Fda and the CDC”, he says to Buongiorno, on Sky Tg24, referring to the green light arrived in America not only by the American drug agency but also by the control body on public health.

Read also

In general, on the covid epidemic in Italy, Locatelli notes that “there is an increase in viral circulation that in some European countries has had an impact on services, in Italy the situation is significantly more favorable thanks to vaccines and the maintenance of non pharmacological such as use of masks and distancing. We must not let our guard down, as demonstrated by what happened in Friuli “.


“The scientific evidence on the trend of infections as a function of the time elapsed from vaccination / recovery, the probable future expansion of the vaccination offer to the audience 5-11 years and, above all, the increase in positive cases at the beginning of the season of major respiratory diseases suggest the advisability of scheduling the administration of third doses without delay respecting the times indicated by the health authorities, ie starting from the 181st day from the completion of the primary vaccination cycle “. This is what the Covid emergency commissioner, General Francesco Paolo Figliuolo writes, in a circular bearing ‘Indications on the continuation of the vaccination campaign’.

“A planning in this sense of the administration of the ‘booster’ doses – adds Figliuolo – would also respond to the need to ensure a homogeneous development of the vaccination campaign throughout the national territory; accurately plan the procurement of drugs, aids and necessary health materials to carry out vaccinations; allow any concomitant administration of the flu vaccine to the categories of subjects for which this seasonal vaccination is recommended; manage the organizational machinery still in place, taking into account the rationalization of the hubs still in progress “.

Although he considers “probable” the expansion of the vaccine also to the age group 5-11 and does not exclude the expansion of the targets for booster doses, Figliuolo nella circola explains how “at the moment there are no” booster doses “for further potential target groups (eg school sector, security / defense, etc.), subject to any future recommendations by the competent health authorities “. In any case, according to the commissioner, the Regions will act in accordance with the provisions of the circular “in the event of a future expansion of the target groups for the primary vaccination cycle (pediatric population in the 5-11 year range) or of the booster dose (for example age groups under 60) “.


The conclusion of the review that the European Medicines Agency Ema is conducting on Pfizer / BioNTech’s Comirnaty * in the 5-11 age group is “expected in December”, announces Marco Cavaleri, head of Vaccines and Therapeutic Products for Covid- 19 of the EU regulatory body, during the periodic update for the press. Cavaleri stresses that the timing envisaged is “reduced” compared to that of “other similar reviews”. In the decision-making process, he states, “we will also consider additional data collected and submitted” to the agency “by BioNTech / Pfizer as part of an ongoing pediatric study.” Comirnaty has been authorized these days for children aged 5 to 11 in the US, both by the Fda drug agency and by the Centers for Disease Control and Prevention (Cdc).

PREV Dead Toni Santagata, with ‘Squadra grande, my team’ sang the Italy of 1982
NEXT “It’s mom’s cooking”